Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Med Arch ; 73(2): 109-112, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31391698

RESUMEN

INTRODUCTION: Cataract surgery is a widely used procedure around the world. After cataract surgery, one of the important points is that oxidative stress may cause postoperative corneal edema and vision loss. AIM: In this study, we aim to reduce the oxidative stress and related conditions that may develop during intraoperative and postoperative FAKO + IOL implantation. MATERIAL AND METHODS: Total amount of 32 patients with cataract were included to the study. The patients were classified as two groups randomly and the same surgical procedure was applied to the patients in both groups, except using visudrop. Group I was defined as a control group and routine FAKO + IOL implantation surgery was performed. In Group II, after the sideport was opened at the beginning of the operation, 0.5 cc visudrop (coenzyme q + vitamin E + hypermellosis) was given to the anterior camara. After the operation, 0.5 cc visudrop was also given to the anterior camara. Postoperative examination findings were compared statistically. RESULTS: In Group II, postoperative 1st day and postoperative 7th day visual acuities were significantly higher than in Group I. In Group II, postoperative 1st day and postoperative 7th day visual acuity increments were significantly higher than in Group I. In Group I, postoperative 1st day and 7th day pachymetry value increments were significantly higher than in Group II. CONCLUSION: Using visudrop during the FAKO + IOL implantation may be an effective method for postoperative corneal edema and vision.


Asunto(s)
Antioxidantes/uso terapéutico , Implantación de Lentes Intraoculares/métodos , Micronutrientes/uso terapéutico , Facoemulsificación/métodos , Cuidados Posoperatorios/métodos , Ubiquinona/uso terapéutico , Vitamina E/uso terapéutico , Administración Oftálmica , Anciano , Anciano de 80 o más Años , Edema Corneal/epidemiología , Paquimetría Corneal , Femenino , Humanos , Cuidados Intraoperatorios/métodos , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Complicaciones Posoperatorias/epidemiología , Tonometría Ocular
2.
Pak J Med Sci ; 30(3): 477-82, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24948962

RESUMEN

OBJECTIVE: The aim of this study was to investigate the association between intraocular pressure and metabolic syndrome by comparing central corneal thicknesses. METHODS: One hundred sixty-two subjects were enrolled in this cross-sectional study, with 89 subjects in a metabolic syndrome group and 73 subjects in a control group. Ophthalmological examinations, including intraocular pressure and central corneal thickness measurements, were performed on each subject. Serum fasting glucose, triglyceride and HDL cholesterol levels were measured, and waist circumference, systolic and diastolic blood pressure of all patients were recorded. RESULTS: Participants with metabolic syndrome had a significantly higher intraocular pressure than those without metabolic syndrome (p = 0.008), and there was no statistically significant difference between the central corneal thicknesses of the two groups (p = 0.553). Most of the metabolic syndrome components were associated with higher intraocular pressure (p < 0.05). CONCLUSIONS: There is a relationship between metabolic syndrome and intraocular pressure, but no association between metabolic syndrome and central corneal thicknesses. Intraocular pressure is affected by central corneal thicknesses, and intraocular pressure is used to correct according to the central corneal thicknesses measurement. To our knowledge, this is the first study that determines the positive relationship between metabolic syndrome and intraocular pressure by comparing the central corneal thicknesses of the groups.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...